Chargement en cours...
LiCABEDS II. Modeling of Ligand Selectivity for G-protein Coupled Cannabinoid Receptors
The cannabinoid receptor subtype 2 (CB2) is a promising therapeutic target for blood cancer, pain relief, osteoporosis, and immune system disease. The recent withdrawal of Rimonabant, which targets at another closely related cannabinoid receptor (CB1), accentuates the importance of selectivity for t...
Enregistré dans:
| Auteurs principaux: | , , , , |
|---|---|
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
2013
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3967758/ https://ncbi.nlm.nih.gov/pubmed/23278450 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1021/ci3003914 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|